PALATIN TECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
PALATIN TECHNOLOGIES, INC. (PTN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.30% for the 12-month period ending 2024-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-09-23
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.30%, a 10.26% increase from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.90%, a 21.88% increase from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 3.20%, a 220.00% increase from fiscal 2021.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 1.00%, a 100.00% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2024-06-30 | 4.30% 10-K · filed 2025-09-23 | |||
| 2024-03-31 | 4.16% 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | 3.87% 10-Q · filed 2024-02-14 | |||
| 2023-06-30 | 3.90% 10-K · filed 2024-09-30 | |||
| 2022-06-30 | 3.20% 10-K · filed 2023-09-28 | |||
| 2021-06-30 | 1.00% 10-K · filed 2022-09-22 | |||
| 2020-06-30 | 0.50% 10-K · filed 2021-09-28 | |||
| 2019-06-30 | 1.90% 10-K · filed 2020-09-25 | |||
| 2018-06-30 | 1.80% 10-K · filed 2020-09-25 | |||
| 2017-06-30 | 1.70% 10-K · filed 2019-09-12 | |||
| 2016-06-30 | 1.40% 10-K · filed 2018-09-13 | |||
| 2015-06-30 | 1.90% 10-K · filed 2017-09-25 | |||
| 2014-06-30 | 1.90% 10-K · filed 2016-09-19 | |||
| 2013-06-30 | 1.80% 10-K · filed 2015-09-18 | |||
| 2011-05-11 | 2.22% 10-K · filed 2012-09-10 | |||
| 2011-03-01 | 2.47% 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |